Ministerial talks for the Trans-Pacific Partnership (TPP) collapsed in Maui last month when trade ministers sparred over issues including monopolies for biotech drugs, which include many cancer treatments. Talks resumed this...
Read MoreIssues New Compulsory Licenses; Signs Harmful Trade Agreement with the EU [Luz Marina Umbasia and Peter Maybarduk, Link to PDF] In July, Ecuador issued four compulsory licenses for medicines targeting cancer and arthritis...
Read MoreThe Office of the US Trade Representative’s 2014 Special 301 Report is expected out shortly. The 301 Report places countries on a watch list for practices the US Government believes reflect “inadequate” intellectual property...
Read MoreLast Thursday the Energy and Commerce committee of the U.S. House of Representatives held a hearing entitled, “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting US Companies.” The hearing is part of a recent...
Read MoreSpecial 301 is an annual report by the Office of the US Trade Representative (USTR) which places countries on a “watch list” if USTR would like to see greater changes in their intellectual property rules or enforcement practice....
Read MorePrecedent-Setting Government Order has Extraordinary Lifesaving Potential On September 3, the government of Indonesia took a quiet but exceptionally important step to expand access to medicines and help save and improve lives of...
Read MoreRollbacks of Modest Bush-Era Improvements on Access to Medicines Would Empower Big Pharma, Expand Monopolies WASHINGTON, D.C. – To achieve the “AIDS-free generation” for which President Barack Obama and Secretary of State...
Read More[Reposted from the citizenvox blog.] The Trans-Pacific Partnership (TPP) is a massive package of proposed new economic rules for the Asia-Pacific region (including the US), heavily influenced by corporate priorities through the...
Read MoreBoth sides appeal in ongoing civil society lawsuit for compulsory license A Colombian administrative judge has ruled that Abbott Laboratories and the Ministry of Health threatened and violated collective rights to public health...
Read MorePublic Citizen has published “Dangers for Access to Medicines in the Trans-Pacific Partnership Agreement: Comparative Analysis of the U.S. Intellectual Property Proposal and Australian Law.” Click here for the...
Read MoreGroups Seek Generic Competition for Abbott’s Patented Lifesaving Treatments WASHINGTON, D.C. – Today, public health groups in a dozen countries launch a campaign to challenge Abbott Laboratories’ monopolistic hold on...
Read MoreIn October 2009, Ecuador’s President Rafael Correa issued Decree 118 to improve access to medicines and support public health programs through a protocol that would reduce drug costs. The protocol established procedures...
Read More
Comments on: Civil Society Documents Comments on: industry | infojustice